Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
toxicity to reproduction: other studies
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
year of publication: 2007
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: secondary source, original data not available

Data source

Reference
Reference Type:
secondary source
Title:
Series on Testing and Assessment, Number 67: Report of the validation of the uterotrophic bioassay: additional data supporting the test guideline on the uterotrophic bioassay in rodents.
Author:
OECD (Organisation for Economic Co-operation and Development)
Year:
2007
Bibliographic source:
ENV/JM/MONO(2007)19 (http://appli1.oecd.org/olis/2007doc.nsf/linkto/env-jm-mono(2007)19; printed 20-12-2008)
Report date:
2007

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
other: OECD TG 440
Deviations:
not specified
GLP compliance:
not specified
Type of method:
in vivo

Test material

Constituent 1
Chemical structure
Reference substance name:
3,3'-dichlorobenzidine dihydrochloride
EC Number:
210-323-0
EC Name:
3,3'-dichlorobenzidine dihydrochloride
Cas Number:
612-83-9
Molecular formula:
C12H10Cl2N2.2ClH
IUPAC Name:
3,3'-dichloro-[1,1'-biphenyl]-4,4'-diamine dihydrochloride

Test animals

Species:
rat
Strain:
not specified
Sex:
female
Details on test animals or test system and environmental conditions:
immature rats (20 days old at the beginning of the exposure period)

Administration / exposure

Route of administration:
subcutaneous
Vehicle:
not specified
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
3 days
Frequency of treatment:
3 times on three consecutive days
Doses / concentrations
Remarks:
Doses / Concentrations:

Basis:
no data
Control animals:
not specified

Results and discussion

Effect levels

Dose descriptor:
NOAEL
Remarks on result:
not determinable
Remarks:
no NOAEL identified

Observed effects

- The test substance gave a negative result in the uterotrophic assay regarding estrogenicity and antiestrogenicity.
- hER binding activity (RBA) was 0.000441
- hERalpha agonist activity, PC10 (M): 1.79E-07

Applicant's summary and conclusion

Conclusions:
The test substance gave a negative result in the uterotrophic assay regarding estrogenicity and antiestrogenicity. Human estrogen receptor binding activity (RBA) and human estrogen receptor alpha agonist activity were very low (0.000441 and PC 10: 1.79E-07 M, respectively).